Displaying 10 out of 5 results

  1. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda fails late-stage study in liver cancer patients

    Merck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a ...
  2. Faster, targeted therapy for liver cancer patients
    Media playtime

    Faster, targeted therapy for liver cancer patients

    Doctors and scientists in Singapore are collaborating with a Korean academic medical centre on a programme that hopes to administer targeted ...
  3. New Content Item

    Liver cancer patients wanted for 'first-in-the-world' trial led by National Cancer Centre

    The trial is the first in the world to combine two types of treatments, one of which is used for liver cancer patients who are unsuitable for ...